Binder, E B <br/><br/>
Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.  [electronic resource] 

 -  The Journal of neuroscience : the official journal of the Society for Neuroscience  Jan 2001 
 - 601-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1529-2401 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acoustic Stimulation<br/>Adamantane--analogs & derivatives<br/>Animals<br/>Antipsychotic Agents--pharmacology<br/>Behavior, Animal--drug effects<br/>Brain--metabolism<br/>Conditioning, Classical--drug effects<br/>Dibenzothiazepines--pharmacology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Electroshock<br/>Female<br/>Haloperidol--pharmacology<br/>Imidazoles--pharmacology<br/>Inhibition, Psychological<br/>Neurotensin--genetics<br/>Photic Stimulation<br/>Psychomotor Performance--drug effects<br/>Quetiapine Fumarate<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Long-Evans<br/>Reaction Time--drug effects<br/>Receptors, Neurotensin--agonists<br/>Reflex, Startle--drug effects<br/>Schizophrenia--metabolism<br/>Social Isolation<br/>Synaptic Transmission--drug effects